VivaVision Biotech Reports Topline P-II Trial Data of VVN461 for Non-Infectious Anterior Uveitis
Shots: VivaVision has reported topline
Ipsen Reports P-II (ELMWOOD) Trial Data of Elafibranor for Primary Sclerosing Cholangitis (PSC)
Shots: Ipsen has reported P-II (
Sebela Pharmaceuticals Reports Topline P-III (TRIUMpH) Program Data of Tegoprazan for Gastroesophageal Reflux Disease (GERD)
Shots: TRIUMpH program consists of 2 P-III trials assessing tegoprazan in US GERD...
BMS Reports Topline P-III (ARISE) Trial Data of Cobenfy as an Adjunctive Therapy for Schizophrenia
Shots: The P-III (ARISE) trial assessed Cobenfy (xanomeline & trospium chlorid...
HUTCHMED Reports Enrollment Completion in P-II Trial of Savolitinib for Gastric Cancer in China
Shots: HUTCHMED has completed pts enrollment in
